Showing results (2031-2040 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Surgical management of breast cancer: today and tomorrowRichard J BoldCancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cellsYongqing Liu, Mabood Qureshi, Jim XiangCancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Mitogen therapy for biological warfare/terrorist attacks and viral hemorrhagic fever controlBruce M WimerCancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasisGilles Mees, Philippe Fonteyne, Wim Ceelen, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Inhibition growth and metastasis of melanoma by 4-1BBL expressed in normal tissue cells by regulating the function of immune cellsQiu Hui, Xu Yu, Zhang Hui, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
A novel Bacillus Calmette-Guérin-based breast cancer vaccine that coexpresses multiple tandem repeats of MUC1 and CD80 breaks the immune tolerance and inhibits MUC1-positive breast cancer growthShifang Yuan, Changhong Shi, Yonggang Lv, et al.Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Continuous infusion interleukin-2 and antihistamines in metastatic kidney cancerPaul R Walker, Sadik A Khuder, Walter D Y QuanCancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2Diane E Milenic, Kayhan Garmestani, Erik D Brady, et al.Cancer Biotherapy & Radiopharmaceuticals|June 7, 2025
PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 UpregulationTianyi Zhang, Zhuoshi Li, Shiqing Wang, et al.Cancer Biotherapy & Radiopharmaceuticals|June 17, 2025
Radiopharmaceutical Advancements in Anesthesia and Orthopedic Oncology: A Paradigm Shift in Cancer Biotherapy and Targeted TherapyShu Su, Wanpeng Zheng, Mingbin HuangPageof 224